These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 39027689)

  • 1. Salvage low-dose-rate brachytherapy for locally recurrent prostate cancer after definitive irradiation.
    Meraouna Y; Blanchard P; Losa S; Labib A; Krhili S; Pommier P; Crehange G; Flam T; Cosset JM; Kissel M
    Clin Transl Radiat Oncol; 2024 Sep; 48():100809. PubMed ID: 39027689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage I-125 brachytherapy for locally-recurrent prostate cancer after radiotherapy.
    Pons-Llanas O; Burgos-Burgos J; Roldan-Ortega S; Conde-Moreno A; Celada-Alvarez F; Ruiz-Martinez JC; Lliso-Valverde F; Tormo-Micó A; Perez-Calatayud J; López-Torrecilla J
    Rep Pract Oncol Radiother; 2020; 25(5):754-759. PubMed ID: 32684865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
    Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM
    Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage brachytherapy for locally-recurrent prostate cancer after radiation therapy: A comparison of efficacy and toxicity outcomes with high-dose rate and low-dose rate brachytherapy.
    Henríquez López I; González-San Segundo C; Vegas JO; Gutierrez C; Hervas A; Cabeza Rodriguez MÁ; Valero Albarrán J; Rodríguez Villalba S; Álvarez Gonzalez A; Sancho Pardo G; Zapatero A; Álvaro PC
    Radiother Oncol; 2019 Dec; 141():156-163. PubMed ID: 31570236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reirradiation salvage radiotherapy for recurrent prostate cancer after primary low-dose brachytherapy.
    Muñoz Muñoz Ó; Gomis Sellés E; Delgado León BD; Mateos Perez JC; Baeza Trujillo M; Perucha Ortega M; López Guerra JL; Cabrera Roldán P
    Clin Transl Oncol; 2024 Apr; 26(4):872-879. PubMed ID: 37672205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage brachytherapy for recurrent prostate cancer after definitive radiation therapy: A comparison of low-dose-rate and high-dose-rate brachytherapy and the importance of prostate-specific antigen doubling time.
    Kollmeier MA; McBride S; Taggar A; Anderson E; Lin M; Pei X; Weiji S; Voros L; Cohen G; Yamada Y; Zelefsky MJ
    Brachytherapy; 2017; 16(6):1091-1098. PubMed ID: 28838648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and toxicity following salvage high-dose-rate brachytherapy for locally recurrent prostate cancer after radiotherapy.
    Kissel M; Pounou A; Ka K; Alexis A; Irani J; Jereczek-Fossa BA; Terlizzi M; Bossi A; Blanchard P
    Brachytherapy; 2022; 21(4):424-434. PubMed ID: 35331666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocol-based image-guided salvage brachytherapy. Early results in patients with local failure of prostate cancer after radiation therapy.
    Lahmer G; Lotter M; Kreppner S; Fietkau R; Strnad V
    Strahlenther Onkol; 2013 Aug; 189(8):668-74. PubMed ID: 23824103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage brachytherapy in prostate local recurrence after radiation therapy: predicting factors for control and toxicity.
    Henríquez I; Sancho G; Hervás A; Guix B; Pera J; Gutierrez C; Abuchaibe O; Martínez-Monge R; Tormo A; Polo A
    Radiat Oncol; 2014 Apr; 9():102. PubMed ID: 24885287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage low-dose-rate permanent seed brachytherapy for locally recurrent prostate cancer: Association between dose and late toxicity.
    Rose JN; Crook JM; Pickles T; Keyes M; Morris WJ
    Brachytherapy; 2015; 14(3):342-9. PubMed ID: 25727178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of a protocol-based ultrasound-guided salvage brachytherapy as re-irradiation for local recurrent prostate cancer.
    Schönle N; Strnad V; Lotter M; Kreppner S; Fietkau R
    Radiother Oncol; 2020 Sep; 150():201-205. PubMed ID: 32593646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial high-dose-rate brachytherapy as salvage treatment for locally recurrent prostate cancer after definitive radiation therapy: Toxicity and 5-year outcome.
    Jiang P; van der Horst C; Kimmig B; Zinsser F; Poppe B; Luetzen U; Juenemann KP; Dunst J; Siebert FA
    Brachytherapy; 2017; 16(1):186-192. PubMed ID: 28341011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose-rate brachytherapy boost for elderly patients with intermediate to high-risk prostate cancer: 5-year clinical outcome of the PROSTAGE cohort.
    Marotte D; Gal J; Schiappa R; Gautier M; Boulahssass R; Chand-Fouche ME; Hannoun-Levi JM
    Clin Transl Radiat Oncol; 2022 Jul; 35():104-109. PubMed ID: 35692263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage brachytherapy for locally recurrent prostate cancer after single-fraction 19 Gy high-dose-rate brachytherapy: toxicity, prostate-specific antigen kinetics, and cancer control.
    Mayrata E; Espinosa JM; Büchser D; Casquero F; Suárez F; González A; Minguez P; Pérez JF; Miguel IS; Cacicedo J; Gómez-Iturriaga A
    J Contemp Brachytherapy; 2021 Feb; 13(1):12-17. PubMed ID: 34025731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-gland salvage treatment for recurrent prostate cancer after initial definitive radiotherapy: A case series of
    Sutani S; Yorozu A; Toya K; Nishiyama T; Ozu C; Yagi Y; Nakamura K; Saito S
    J Contemp Brachytherapy; 2019 Jun; 11(3):201-206. PubMed ID: 31435426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage external beam radiotherapy for locally recurrent prostate cancer after definitive brachytherapy.
    Rutenberg MS; Meister M; Amin PP; Hussain A; Naslund MJ; Kwok Y
    Brachytherapy; 2016; 15(6):722-729. PubMed ID: 27693225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-reported outcomes after Low-dose-rate versus High-dose-rate brachytherapy boost in combination with external beam radiation for intermediate and high risk prostate cancer.
    Dhere VR; Fischer-Valuck BW; Goyal S; Liu Y; Morgan TM; Ghavidel E; Moghanaki DM; Hershatter BW; Patel PR; Jani AB; Godette KD; Rossi PJ; Patel SA
    Brachytherapy; 2021; 20(6):1130-1138. PubMed ID: 34417136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage of locally recurrent prostate cancer after external beam radiation using reduced-dose brachytherapy with neoadjuvant plus adjuvant androgen deprivation.
    Baumann BC; Baumann JC; Christodouleas JP; Soffen E
    Brachytherapy; 2017; 16(2):291-298. PubMed ID: 28139422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Safety and Efficacy Profile of Homogeneously Dosed Salvage Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Recurrences After Low Dose Rate (LDR) Brachytherapy.
    Nikitas J; Cao M; Nickols NG; Valle L; Steinberg ML; Kishan AU
    Clin Genitourin Cancer; 2023 Apr; 21(2):208-212. PubMed ID: 36739178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prospective Phase 2 Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Cancer After External Beam Radiation Therapy (NRG Oncology/RTOG-0526).
    Crook JM; Zhang P; Pisansky TM; Trabulsi EJ; Amin MB; Bice W; Morton G; Pervez N; Vigneault E; Catton C; Michalski J; Roach M; Beyer D; Jani A; Horwitz E; Donavanik V; Sandler H
    Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):335-343. PubMed ID: 30312717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.